Professor Florian Kronenberg, Medical University of Innsbruck, Austria, shows how genetic studies have paved the way for understanding the regulation of Lp(a) and its causal association with cardiovascular outcomes, and potential for novel targeted therapies.
Educational Partners and Supporters
Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.
(Founding Partner)